Nadim Ahmed has over 25 years of leadership experience in oncology development and commercialization. In his current role as CEO of Cullinan Oncology, Nadim oversees an expert team focused on creating new standards of care for patients with cancer through a modality-agnostic, targeted oncology approach to building a diversified pipeline of first-in-class and best-in-class therapeutics. Since joining the company in 2021, Nadim has helped Cullinan expand its pipeline from one asset in the clinic to an expected six assets in the clinic by the end of 2023.
He holds a Master of Science degree from Loughborough University, UK and a Bachelor of Science degree from University College London, UK. Nadim currently serves on the Board of Directors for Family Promise, a national non-profit organization helping families impacted by homelessness.
During my 25 years in oncologic drug discovery, development and commercialization, I have seen how economic cycles can skew priorities and slow progress – but we cannot let that happen.